Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of April 2022, with a filing date of April 12, 2022. The document serves as a transaction notification regarding the activities of Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. It details increases in notional interests in GSK securities resulting from the re-investment of dividends paid on April 7, 2022, under the Company's Deferred Annual Bonus Plan.
Key Financial Metrics
The filing does not contain corporate financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial metrics provided relate to specific share transactions:
- Ordinary Shares Price: GBP 17.4100 per share.
- American Depositary Shares (ADS) Price: USD 46.2300 per ADS.
- Transaction Volume: Aggregated volumes for individual executives ranged from 31 ADSs to 2,363 Ordinary Shares.
Material Changes
The filing does not report material changes to the company's financial position, operations, or strategy. The reported changes are strictly limited to the increase in notional shareholdings for specific executives due to dividend re-investment plans. No prior comparable period data is provided for analysis.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, risk factors, or contingencies. It is a regulatory disclosure of specific executive compensation-related transactions.
Important Facts for Investor Verification
- Transaction Nature: All reported transactions were automatic re-investments of dividends, not open-market purchases or sales by executives.
- Executives Involved: Transactions were reported for 15 senior leaders, including CEO Emma Walmsley, CFO Ian Mackay, and CSO Helen Barron.
- Trading Venues: Ordinary Shares were traded on the London Stock Exchange (XLON); ADSs were traded on the New York Stock Exchange (XNYS).
- Timing: All transactions occurred on April 8, 2022, following the dividend payment date of April 7, 2022.